Patent · US Active

Somatostatin analogues

US7939625B2 · kind B2 · utility

0Cited by

4References

2Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rainer Albert · Basel, CH
Wilfried Bauer · Lampenberg, CH
David Bodmer · Klingnau, CH
Christian Bruns · Glückstadt, DE
Ivo Felner · Reinach, CH
Heribert Hellstern · Heitersheim, DE
Ian Lewis · Riehen, CH
Mark Meisenbach · Durmenach, FR
Gisbert Weckbecker · Biel-Benken, CH
Bernhard Wietfeld · Weil am Rhein, DE

Key dates

Filing date	Nov 5, 2008
Grant date	May 10, 2011
Priority date	—
Expiry date	Nov 5, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.